Back to results

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Primary Purpose

Diabetes Mellitus

Status

Completed

Phase

Phase 4

Locations

International

Study Type

Interventional

Intervention

Albiglutide 30 mg

Albiglutide 50 mg

Albiglutide matching placebo

About this trial

This is an interventional treatment trial for Diabetes Mellitus focused on measuring cardiovascular events /outcomes, Type 2 diabetes mellitus, albiglutide, glucagon-like peptide-1 receptor agonist

Eligibility Criteria

40 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Men or women at least 40 years old. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy.
Diagnosis of type 2 diabetes.
Established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease.
HbA1c >7.0% (53 mmol/mol) (based on the most recent documented laboratory measurement within 6 months).
Able and willing to provide informed consent.

Exclusion Criteria:

Severely reduced kidney function: eGFR <30 ml/min/1.73 m^2 (based on the last measured and documented laboratory measurement within 6 months) or renal replacement therapy.
Use of a GLP-1 receptor agonist at Screening.
Severe gastroparesis
History of pancreatitis or considered clinically at significant risk of developing pancreatitis during the course of the study.
Personal or family history of medullary carcinoma of the thyroid or subject with multiple endocrine neoplasia type 2 (MEN-2). Personal history of pancreatic neuroendocrine tumours.
Medical history which might limit the subject's ability to take trial treatments for the duration of the study or to otherwise complete the study.
Breastfeeding, pregnancy, or planning a pregnancy during the course of the study. Note: a pregnancy test will be performed on all women of child bearing potential prior to study entry.
Known allergy to any GLP-1 receptor agonist or excipients of albiglutide.
Use of another investigational product within 30 days or according to local regulations, or currently enrolled in a study of an investigational device.
Any other reason the investigator deems the subject to be unsuitable for the study.

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Albiglutide

Placebo

Arm Description

Albiglutide once weekly by subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed. Albiglutide will be administered in addition to standard therapy for diabetes and cardiovascular health.

Placebo once weekly by subcutaneous injection. Placebo will be administered in addition to standard therapy for diabetes and cardiovascular health.

Outcomes

Primary Outcome Measures

Time to First Occurrence of Major Adverse Cardiovascular Events (MACE) During Cardiovascular (CV) Follow-up Time Period

Time to MACE defined as the time to first occurrence of Cardiovascular Endpoint Committee (CEC)-adjudicated MACE (CV death, myocardial infarction [MI] or stroke) was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period. The analysis was performed on the Intent to Treat (ITT) Population which comprised of all randomized participants excluding participants who did not provide consent.

Secondary Outcome Measures

Time to First Occurrence of MACE or Urgent Revascularization for Unstable Angina

Time to first occurrence of CEC-adjudicated MACE (CV death, MI or stroke) or urgent revascularization for unstable angina was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.

Time to Adjudicated CV Death

Time to adjudicated CV death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.

Time to First Occurrence of Adjudicated MI

Time to first occurrence of adjudicated MI was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.

Time to First Occurrence of Adjudicated Stroke

Time to first occurrence of adjudicated stroke was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.

Time to First Occurrence of Adjudicated CV Death or Hospitalization for Heart Failure (HF)

Time to first occurrence of adjudicated CV death or hospitalization for HF was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the CV follow-up time period.

Time to Initiation of Insulin of More Than 3 Months Duration for Those Participants Not Treated With Insulin at Study Start

Time to initiation of insulin of more than 3 months duration in participants not treated with insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Non-Insulin Population which comprised of participants in the ITT Population who were not on insulin at Baseline.

Time to Initiation of Prandial Insulin in Those Participants on Basal Insulin at Study Start

Time to initiation of prandial insulin in those participants on basal insulin at study start was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period. The analysis was performed on Basal Insulin Population which comprised of participants in the ITT Population who were on basal insulin but not on other insulin at Baseline (i.e., will not include a participant on a mixed insulin or on a prandial-only insulin).

Percentage of Participants Achieving Composite Metabolic Endpoint

Percentage of participants achieving composite metabolic endpoint defined as the percentage of participants achieving glycemic control (glycated hemoglobin [HbA1c] <=7% ) with no severe hypoglycemic incidents and weight gain < 5%. Final Assessment is the latest post-Baseline assessment of both HbA1c and weight.

Time to First Occurrence of a Clinically Important Microvascular Event

Clinically important microvascular events were defined as the following: need for renal transplant or dialysis, new diabetes-related blindness, and procedures (laser photocoagulation or anti-vascular endothelial growth factor treatment or vitrectomy for diabetic retinopathy/eye disease). Time to first occurrence of a clinically important microvascular event was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants with at least 1 event)/first event person-years) is presented along with 95% confidence interval. First event person-years=(cumulative total time to first event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the on-therapy and post-therapy AE time period.

Change From Baseline in HbA1c

Change from Baseline in HbA1c was analyzed using mixed model repeated measures (MMRM) including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in HbA1c using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data is presented.

Change From Baseline in Body Weight

Change from Baseline in body weight was analyzed using mixed model repeated measures including observed case data (does not impute any missing data). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.

Change From Baseline in Treatment Related Impact Measures-Diabetes (TRIM-D) Total Score

The TRIM-D is a 28 item treatment satisfaction measure with 5 domains assessing Treatment Burden, Daily Life, Diabetes Management, Compliance and Psychological Health. The raw score ranges for each subscale were: treatment burden (6 to 30), daily life (5 to 25), diabetes management (5 to 25), compliance (4 to 20) and psychological health (8 to 40), higher scores indicating better health state. Total raw score was determined by summing the raw scores for each of the subscales and the total score (transformed) was determined as [(raw score minus lowest possible raw score)/possible raw score range] x100. The possible total (transformed) score range is 0-100, where higher scores indicated better health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.

Change From Baseline in EuroQol- 5 Dimension (EQ-5D) Visual Analogue Scale (VAS) Score

The EQ-5D is a standardized instrument used to evaluate generic health-related quality of life, comprising 5 domains: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. It provides a simple descriptive profile and a single index value for health status. The EQ-5D self-reported questionnaire includes a visual analog scale (VAS), which records the respondent's self-rated health status on a graduated (0-100) scale, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.

Time to Death

Time to death was analyzed using a Cox Proportional Hazards regression model with treatment group as the only covariate. The incidence rate per 100 person years (100*number of participants who died/endpoint person-years) is presented along with 95% confidence interval. Endpoint person-years=(cumulative total time to event for participants who have the event+cumulative total of censored time for participants without the event)/365.25, based on the Vital Status follow-up time period.

Number of Participants With Non-fatal Serious Adverse Events (SAEs)

SAE is defined as any untoward medical occurrence that, at any dose: results in death; is life-threatening; requires hospitalization or prolongation of existing hospitalization; results in disability/incapacity; is a congenital anomaly/birth defect; other important medical events that may not be immediately life-threatening or result in death or hospitalization but may jeopardize the participant or may require medical or surgical intervention to prevent one of the other outcomes listed before; is associated with liver injury and impaired liver function. Number of participants with on-therapy non-fatal SAEs are presented. Safety Population comprised of all randomized participants who received at least one dose of study treatment.

Number of Participants With Adverse Events (AEs) Leading to Discontinuation of Investigational Product (AELD)

The number of participants with on-therapy AEs leading to discontinuation of investigational product is reported.

Number of Participants With AEs of Special Interest

The protocol defined AEs of special interest included: development of thyroid cancer; hematologic malignancy; pancreatic cancer; pancreatitis (investigator reported and pancreatitis positively adjudicated by the Pancreatic Adjudication Committee [PAC]); investigational product injection site reactions; immunological reactions; severe hypoglycemic events; hepatic events; hepatic enzyme elevations (including gamma glutamyl transferase [GGT]); serious gastrointestinal (GI) events; appendicitis; atrial fibrillation/flutter; pneumonia; worsening renal function and diabetic retinopathy. The number of participants with on-therapy AEs of special interest is reported.

Change in Estimated Glomerular Filtration Rate (eGFR) Calculated Using Modification of Diet in Renal Disease (MDRD) Formula

Blood samples were collected for the measurement of serum creatinine. Serum creatinine values were used to calculate eGFR using the MDRD formula, eGFR=175 x (serum creatinine)^-1.154 x (Age)^-0.203 x (0.742 if female) x (1.212 if African American). Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value. Change from Baseline in eGFR using Baseline data from Local or Central Laboratory, and post-Baseline Central Laboratory data for the on-treatment time period is presented.

Change From Baseline in Blood Pressure

Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were taken with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.

Change From Baseline in Heart Rate

Heart rate was measured with the participant in a semi-recumbent or seated position after at least a 5-minute rest period. Baseline is the last non-missing value assessed on or before treatment start date. Change from Baseline is the value at specified time point minus the Baseline value.

Full Information

NCT ID

NCT02465515

First Posted

June 4, 2015

Last Updated

February 11, 2019

Sponsor

GlaxoSmithKline

Collaborators

Duke Clinical Research Institute

1. Study Identification

Unique Protocol Identification Number

NCT02465515

Brief Title

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Official Title

A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus

Study Type

Interventional

2. Study Status

Record Verification Date

February 2019

Overall Recruitment Status

Completed

Study Start Date

July 1, 2015 (Actual)

Primary Completion Date

February 20, 2018 (Actual)

Study Completion Date

March 14, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title

Sponsor

Name of the Sponsor

GlaxoSmithKline

Collaborators

Duke Clinical Research Institute

4. Oversight

Data Monitoring Committee

Yes

5. Study Description

Brief Summary

Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to treat type 2 diabetes This study will test whether albiglutide affects the occurrence of major cardiovascular events such as heart attacks or strokes and other important medical outcomes in persons with type 2 diabetes, when used alone or added to other diabetes treatments.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study

Diabetes Mellitus

Keywords

cardiovascular events /outcomes, Type 2 diabetes mellitus, albiglutide, glucagon-like peptide-1 receptor agonist

7. Study Design

Primary Purpose

Treatment

Study Phase

Phase 4

Interventional Study Model

Parallel Assignment

Masking

ParticipantCare ProviderInvestigatorOutcomes Assessor

Allocation

Randomized

Enrollment

9463 (Actual)

8. Arms, Groups, and Interventions

Arm Title

Albiglutide

Arm Type

Experimental

Arm Description

Arm Title

Placebo

Arm Type

Placebo Comparator

Arm Description

Placebo once weekly by subcutaneous injection. Placebo will be administered in addition to standard therapy for diabetes and cardiovascular health.

Intervention Type

Biological

Intervention Name(s)

Albiglutide 30 mg

Intervention Description

Once weekly subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed.

Intervention Type

Biological

Intervention Name(s)

Albiglutide 50 mg

Intervention Description

Once weekly subcutaneous injection. Starting dose 30 mg may be increased to 50 mg if needed.

Intervention Type

Biological

Intervention Name(s)

Albiglutide matching placebo

Intervention Description

Once weekly subcutaneous injection. Matched to 30 mg and 50 mg albiglutide.

Primary Outcome Measure Information:

Title

Time to First Occurrence of Major Adverse Cardiovascular Events (MACE) During Cardiovascular (CV) Follow-up Time Period

Description

Time Frame

Median of 1.65 person years for CV follow-up time period

Secondary Outcome Measure Information:

Title

Time to First Occurrence of MACE or Urgent Revascularization for Unstable Angina

Description

Time Frame

Median of 1.65 person years for CV follow-up time period

Title

Time to Adjudicated CV Death

Description

Time Frame

Median of 1.65 person years for the CV follow-up time period

Title

Time to First Occurrence of Adjudicated MI

Description

Time Frame

Median of 1.65 person years for CV follow-up time period

Title

Time to First Occurrence of Adjudicated Stroke

Description

Time Frame

Median of 1.65 person years for CV follow-up time period

Title

Time to First Occurrence of Adjudicated CV Death or Hospitalization for Heart Failure (HF)

Description

Time Frame

Median of 1.65 person years for CV follow-up time period

Title

Time to Initiation of Insulin of More Than 3 Months Duration for Those Participants Not Treated With Insulin at Study Start

Description

Time Frame

Up to 2.7 years

Title

Time to Initiation of Prandial Insulin in Those Participants on Basal Insulin at Study Start

Description

Time Frame

Up to 2.7 years

Title

Percentage of Participants Achieving Composite Metabolic Endpoint

Description

Time Frame

Months 8, 16, 24 and final assessment (up to 2.7 years)

Title

Time to First Occurrence of a Clinically Important Microvascular Event

Description

Time Frame

Up to 2.7 years

Title

Change From Baseline in HbA1c

Description

Time Frame

Baseline and Months 8 and 16

Title

Change From Baseline in Body Weight

Description

Time Frame

Baseline and Months 8 and 16

Title

Change From Baseline in Treatment Related Impact Measures-Diabetes (TRIM-D) Total Score

Description

Time Frame

Baseline and Months 8 and 16

Title

Change From Baseline in EuroQol- 5 Dimension (EQ-5D) Visual Analogue Scale (VAS) Score

Description

Time Frame

Baseline and Months 8 and 16

Title

Time to Death

Description

Time Frame

Median of 1.73 years for the Vital Status follow-up time period

Title

Number of Participants With Non-fatal Serious Adverse Events (SAEs)

Description

Time Frame

Up to 2.7 years

Title

Number of Participants With Adverse Events (AEs) Leading to Discontinuation of Investigational Product (AELD)

Description

The number of participants with on-therapy AEs leading to discontinuation of investigational product is reported.

Time Frame

Up to 2.7 years

Title

Number of Participants With AEs of Special Interest

Description

Time Frame

Up to 2.7 years

Title

Change in Estimated Glomerular Filtration Rate (eGFR) Calculated Using Modification of Diet in Renal Disease (MDRD) Formula

Description

Time Frame

Baseline and Months 8 and 16

Title

Change From Baseline in Blood Pressure

Description

Time Frame

Baseline and Months 8,16,24 and end of study (up to 2.7 years)

Title

Change From Baseline in Heart Rate

Description

Time Frame

Baseline and Months 8, 16, 24 and end of study (up to 2.7 years)

10. Eligibility

Sex

All

Minimum Age & Unit of Time

40 Years

Accepts Healthy Volunteers

Eligibility Criteria

Inclusion Criteria: Men or women at least 40 years old. Women must be post-menopausal or using a highly effective method for avoidance of pregnancy. Diagnosis of type 2 diabetes. Established cardiovascular disease with at least one of the following: coronary artery disease, cerebrovascular disease, or peripheral arterial disease. HbA1c >7.0% (53 mmol/mol) (based on the most recent documented laboratory measurement within 6 months). Able and willing to provide informed consent. Exclusion Criteria: Severely reduced kidney function: eGFR <30 ml/min/1.73 m^2 (based on the last measured and documented laboratory measurement within 6 months) or renal replacement therapy. Use of a GLP-1 receptor agonist at Screening. Severe gastroparesis History of pancreatitis or considered clinically at significant risk of developing pancreatitis during the course of the study. Personal or family history of medullary carcinoma of the thyroid or subject with multiple endocrine neoplasia type 2 (MEN-2). Personal history of pancreatic neuroendocrine tumours. Medical history which might limit the subject's ability to take trial treatments for the duration of the study or to otherwise complete the study. Breastfeeding, pregnancy, or planning a pregnancy during the course of the study. Note: a pregnancy test will be performed on all women of child bearing potential prior to study entry. Known allergy to any GLP-1 receptor agonist or excipients of albiglutide. Use of another investigational product within 30 days or according to local regulations, or currently enrolled in a study of an investigational device. Any other reason the investigator deems the subject to be unsuitable for the study.

Overall Study Officials:

First Name & Middle Initial & Last Name & Degree

GSK Clinical Trials

Organizational Affiliation

GlaxoSmithKline (for GlaxoSmithKline; Human Genome Sciences Inc., a GSK Company; Sirtris, a GSK Company; Stiefel, a GSK Company; ViiV Healthcare)

Official's Role

Study Director

Facility Information:

Facility Name

GSK Investigational Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35211

Country

United States

Facility Name

GSK Investigational Site

City

Birmingham

State/Province

Alabama

ZIP/Postal Code

35235

Country

United States

Facility Name

GSK Investigational Site

City

Mobile

State/Province

Alabama

ZIP/Postal Code

36608

Country

United States

Facility Name

GSK Investigational Site

City

Chandler

State/Province

Arizona

ZIP/Postal Code

85284

Country

United States

Facility Name

GSK Investigational Site

City

Glendale

State/Province

Arizona

ZIP/Postal Code

85308

Country

United States

Facility Name

GSK Investigational Site

City

Goodyear

State/Province

Arizona

ZIP/Postal Code

85395

Country

United States

Facility Name

GSK Investigational Site

City

Tempe

State/Province

Arizona

ZIP/Postal Code

85283

Country

United States

Facility Name

GSK Investigational Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85741

Country

United States

Facility Name

GSK Investigational Site

City

Tucson

State/Province

Arizona

ZIP/Postal Code

85745

Country

United States

Facility Name

GSK Investigational Site

City

Little Rock

State/Province

Arkansas

ZIP/Postal Code

72209

Country

United States

Facility Name

GSK Investigational Site

City

Searcy

State/Province

Arkansas

ZIP/Postal Code

72143

Country

United States

Facility Name

GSK Investigational Site

City

Chula Vista

State/Province

California

ZIP/Postal Code

91910

Country

United States

Facility Name

GSK Investigational Site

City

Lancaster

State/Province

California

ZIP/Postal Code

93534

Country

United States

Facility Name

GSK Investigational Site

City

Lomita

State/Province

California

ZIP/Postal Code

90717

Country

United States

Facility Name

GSK Investigational Site

City

Long Beach

State/Province

California

ZIP/Postal Code

90807

Country

United States

Facility Name

GSK Investigational Site

City

Long Beach

State/Province

California

ZIP/Postal Code

90822

Country

United States

Facility Name

GSK Investigational Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90017

Country

United States

Facility Name

GSK Investigational Site

City

Los Angeles

State/Province

California

ZIP/Postal Code

90073

Country

United States

Facility Name

GSK Investigational Site

City

Moreno Valley

State/Province

California

ZIP/Postal Code

92555

Country

United States

Facility Name

GSK Investigational Site

City

Northridge

State/Province

California

ZIP/Postal Code

91325

Country

United States

Facility Name

GSK Investigational Site

City

Oakland

State/Province

California

ZIP/Postal Code

94607

Country

United States

Facility Name

GSK Investigational Site

City

San Diego

State/Province

California

ZIP/Postal Code

92103

Country

United States

Facility Name

GSK Investigational Site

City

San Diego

State/Province

California

ZIP/Postal Code

92117

Country

United States

Facility Name

GSK Investigational Site

City

San Marino

State/Province

California

ZIP/Postal Code

91108

Country

United States

Facility Name

GSK Investigational Site

City

San Ramon

State/Province

California

ZIP/Postal Code

94583

Country

United States

Facility Name

GSK Investigational Site

City

Simi Valley

State/Province

California

ZIP/Postal Code

93065

Country

United States

Facility Name

GSK Investigational Site

City

Stanford

State/Province

California

ZIP/Postal Code

94305

Country

United States

Facility Name

GSK Investigational Site

City

Torrance

State/Province

California

ZIP/Postal Code

90502

Country

United States

Facility Name

GSK Investigational Site

City

Denver

State/Province

Colorado

ZIP/Postal Code

80220

Country

United States

Facility Name

GSK Investigational Site

City

Littleton

State/Province

Colorado

ZIP/Postal Code

80120

Country

United States

Facility Name

GSK Investigational Site

City

Littleton

State/Province

Colorado

ZIP/Postal Code

80127

Country

United States

Facility Name

GSK Investigational Site

City

New Haven

State/Province

Connecticut

ZIP/Postal Code

06511

Country

United States

Facility Name

GSK Investigational Site

City

Belle Glade

State/Province

Florida

ZIP/Postal Code

33430

Country

United States

Facility Name

GSK Investigational Site

City

Bradenton

State/Province

Florida

ZIP/Postal Code

34201

Country

United States

Facility Name

GSK Investigational Site

City

Bradenton

State/Province

Florida

ZIP/Postal Code

34209

Country

United States

Facility Name

GSK Investigational Site

City

Coral Gables

State/Province

Florida

ZIP/Postal Code

33134

Country

United States

Facility Name

GSK Investigational Site

City

Coral Springs

State/Province

Florida

ZIP/Postal Code

33065

Country

United States

Facility Name

GSK Investigational Site

City

Fleming Island

State/Province

Florida

ZIP/Postal Code

32003

Country

United States

Facility Name

GSK Investigational Site

City

Inverness

State/Province

Florida

ZIP/Postal Code

34452

Country

United States

Facility Name

GSK Investigational Site

City

Jacksonville

State/Province

Florida

ZIP/Postal Code

32216

Country

United States

Facility Name

GSK Investigational Site

City

Lake Worth

State/Province

Florida

ZIP/Postal Code

33467

Country

United States

Facility Name

GSK Investigational Site

City

Lakeland

State/Province

Florida

ZIP/Postal Code

33805

Country

United States

Facility Name

GSK Investigational Site

City

Miami

State/Province

Florida

ZIP/Postal Code

33174

Country

United States

Facility Name

GSK Investigational Site

City

Ocala

State/Province

Florida

ZIP/Postal Code

34471

Country

United States

Facility Name

GSK Investigational Site

City

Ponte Vedra

State/Province

Florida

ZIP/Postal Code

32081

Country

United States

Facility Name

GSK Investigational Site

City

Port Charlotte

State/Province

Florida

ZIP/Postal Code

33952

Country

United States

Facility Name

GSK Investigational Site

City

Port Orange

State/Province

Florida

ZIP/Postal Code

32127

Country

United States

Facility Name

GSK Investigational Site

City

Saint Petersburg

State/Province

Florida

ZIP/Postal Code

33713

Country

United States

Facility Name

GSK Investigational Site

City

Vero Beach

State/Province

Florida

ZIP/Postal Code

32960

Country

United States

Facility Name

GSK Investigational Site

City

Wellington

State/Province

Florida

ZIP/Postal Code

33449

Country

United States

Facility Name

GSK Investigational Site

City

Atlanta

State/Province

Georgia

ZIP/Postal Code

30318

Country

United States

Facility Name

GSK Investigational Site

City

Atlanta

State/Province

Georgia

ZIP/Postal Code

30342

Country

United States

Facility Name

GSK Investigational Site

City

Conyers

State/Province

Georgia

ZIP/Postal Code

30094

Country

United States

Facility Name

GSK Investigational Site

City

Cumming

State/Province

Georgia

ZIP/Postal Code

30041

Country

United States

Facility Name

GSK Investigational Site

City

Decatur

State/Province

Georgia

ZIP/Postal Code

30033

Country

United States

Facility Name

GSK Investigational Site

City

Dunwoody

State/Province

Georgia

ZIP/Postal Code

30338

Country

United States

Facility Name

GSK Investigational Site

City

Snellville

State/Province

Georgia

ZIP/Postal Code

30078

Country

United States

Facility Name

GSK Investigational Site

City

Tucker

State/Province

Georgia

ZIP/Postal Code

30084

Country

United States

Facility Name

GSK Investigational Site

City

Aurora

State/Province

Illinois

ZIP/Postal Code

60504

Country

United States

Facility Name

GSK Investigational Site

City

Champaign

State/Province

Illinois

ZIP/Postal Code

61820

Country

United States

Facility Name

GSK Investigational Site

City

Gurnee

State/Province

Illinois

ZIP/Postal Code

60031

Country

United States

Facility Name

GSK Investigational Site

City

Moline

State/Province

Illinois

ZIP/Postal Code

61265

Country

United States

Facility Name

GSK Investigational Site

City

Avon

State/Province

Indiana

ZIP/Postal Code

46123

Country

United States

Facility Name

GSK Investigational Site

City

Franklin

State/Province

Indiana

ZIP/Postal Code

46131

Country

United States

Facility Name

GSK Investigational Site

City

Greenfield

State/Province

Indiana

ZIP/Postal Code

46140

Country

United States

Facility Name

GSK Investigational Site

City

Muncie

State/Province

Indiana

ZIP/Postal Code

47304-

Country

United States

Facility Name

GSK Investigational Site

City

Munster

State/Province

Indiana

ZIP/Postal Code

46321

Country

United States

Facility Name

GSK Investigational Site

City

West Des Moines

State/Province

Iowa

ZIP/Postal Code

50265

Country

United States

Facility Name

GSK Investigational Site

City

Topeka

State/Province

Kansas

ZIP/Postal Code

66606

Country

United States

Facility Name

GSK Investigational Site

City

Lexington

State/Province

Kentucky

ZIP/Postal Code

40503

Country

United States

Facility Name

GSK Investigational Site

City

Louisville

State/Province

Kentucky

ZIP/Postal Code

40213

Country

United States

Facility Name

GSK Investigational Site

City

New Orleans

State/Province

Louisiana

ZIP/Postal Code

70115

Country

United States

Facility Name

GSK Investigational Site

City

Lewiston

State/Province

Maine

ZIP/Postal Code

04240

Country

United States

Facility Name

GSK Investigational Site

City

Annapolis

State/Province

Maryland

ZIP/Postal Code

21401

Country

United States

Facility Name

GSK Investigational Site

City

Saint Cloud

State/Province

Minnesota

ZIP/Postal Code

56303

Country

United States

Facility Name

GSK Investigational Site

City

Saint Paul

State/Province

Minnesota

ZIP/Postal Code

55102

Country

United States

Facility Name

GSK Investigational Site

City

Saint Louis

State/Province

Missouri

ZIP/Postal Code

63136

Country

United States

Facility Name

GSK Investigational Site

City

Omaha

State/Province

Nebraska

ZIP/Postal Code

68124

Country

United States

Facility Name

GSK Investigational Site

City

Las Vegas

State/Province

Nevada

ZIP/Postal Code

89086

Country

United States

Facility Name

GSK Investigational Site

City

Camden

State/Province

New Jersey

ZIP/Postal Code

08103

Country

United States

Facility Name

GSK Investigational Site

City

Haddon Heights

State/Province

New Jersey

ZIP/Postal Code

08035

Country

United States

Facility Name

GSK Investigational Site

City

Albuquerque

State/Province

New Mexico

ZIP/Postal Code

87102

Country

United States

Facility Name

GSK Investigational Site

City

Brooklyn

State/Province

New York

ZIP/Postal Code

11215

Country

United States

Facility Name

GSK Investigational Site

City

North Massapequa

State/Province

New York

ZIP/Postal Code

11758

Country

United States

Facility Name

GSK Investigational Site

City

Charlotte

State/Province

North Carolina

ZIP/Postal Code

28207

Country

United States

Facility Name

GSK Investigational Site

City

Charlotte

State/Province

North Carolina

ZIP/Postal Code

28209

Country

United States

Facility Name

GSK Investigational Site

City

Charlotte

State/Province

North Carolina

ZIP/Postal Code

28277

Country

United States

Facility Name

GSK Investigational Site

City

Hickory

State/Province

North Carolina

ZIP/Postal Code

28601

Country

United States

Facility Name

GSK Investigational Site

City

Rocky Mount

State/Province

North Carolina

ZIP/Postal Code

27804

Country

United States

Facility Name

GSK Investigational Site

City

Salisbury

State/Province

North Carolina

ZIP/Postal Code

28144

Country

United States

Facility Name

GSK Investigational Site

City

Statesville

State/Province

North Carolina

ZIP/Postal Code

28625

Country

United States

Facility Name

GSK Investigational Site

City

Wilmington

State/Province

North Carolina

ZIP/Postal Code

28401

Country

United States

Facility Name

GSK Investigational Site

City

Winston-Salem

State/Province

North Carolina

ZIP/Postal Code

27157

Country

United States

Facility Name

GSK Investigational Site

City

Fargo

State/Province

North Dakota

ZIP/Postal Code

58103

Country

United States

Facility Name

GSK Investigational Site

City

Cleveland

State/Province

Ohio

ZIP/Postal Code

44122

Country

United States

Facility Name

GSK Investigational Site

City

Columbus

State/Province

Ohio

ZIP/Postal Code

43210

Country

United States

Facility Name

GSK Investigational Site

City

Sandusky

State/Province

Ohio

ZIP/Postal Code

44870

Country

United States

Facility Name

GSK Investigational Site

City

Springfield

State/Province

Ohio

ZIP/Postal Code

45504

Country

United States

Facility Name

GSK Investigational Site

City

Toledo

State/Province

Ohio

ZIP/Postal Code

43614

Country

United States

Facility Name

GSK Investigational Site

City

Camp Hill

State/Province

Pennsylvania

ZIP/Postal Code

17011

Country

United States

Facility Name

GSK Investigational Site

City

Feasterville

State/Province

Pennsylvania

ZIP/Postal Code

19053

Country

United States

Facility Name

GSK Investigational Site

City

Harleysville

State/Province

Pennsylvania

ZIP/Postal Code

19438

Country

United States

Facility Name

GSK Investigational Site

City

Jersey Shore

State/Province

Pennsylvania

ZIP/Postal Code

17740

Country

United States

Facility Name

GSK Investigational Site

City

Lansdale

State/Province

Pennsylvania

ZIP/Postal Code

19446

Country

United States

Facility Name

GSK Investigational Site

City

Newport

State/Province

Pennsylvania

ZIP/Postal Code

17074

Country

United States

Facility Name

GSK Investigational Site

City

Penndel

State/Province

Pennsylvania

ZIP/Postal Code

19047

Country

United States

Facility Name

GSK Investigational Site

City

Pittsburgh

State/Province

Pennsylvania

ZIP/Postal Code

15212

Country

United States

Facility Name

GSK Investigational Site

City

Pittsburgh

State/Province

Pennsylvania

ZIP/Postal Code

15240

Country

United States

Facility Name

GSK Investigational Site

City

Sellersville

State/Province

Pennsylvania

ZIP/Postal Code

18960

Country

United States

Facility Name

GSK Investigational Site

City

Pawtucket

State/Province

Rhode Island

ZIP/Postal Code

02860

Country

United States

Facility Name

GSK Investigational Site

City

Anderson

State/Province

South Carolina

ZIP/Postal Code

29621

Country

United States

Facility Name

GSK Investigational Site

City

Columbia

State/Province

South Carolina

ZIP/Postal Code

29223

Country

United States

Facility Name

GSK Investigational Site

City

Myrtle Beach

State/Province

South Carolina

ZIP/Postal Code

29572

Country

United States

Facility Name

GSK Investigational Site

City

Rapid City

State/Province

South Dakota

ZIP/Postal Code

57701

Country

United States

Facility Name

GSK Investigational Site

City

Rapid City

State/Province

South Dakota

ZIP/Postal Code

57702

Country

United States

Facility Name

GSK Investigational Site

City

Bristol

State/Province

Tennessee

ZIP/Postal Code

37620

Country

United States

Facility Name

GSK Investigational Site

City

Kingsport

State/Province

Tennessee

ZIP/Postal Code

37660

Country

United States

Facility Name

GSK Investigational Site

City

Memphis

State/Province

Tennessee

ZIP/Postal Code

38104

Country

United States

Facility Name

GSK Investigational Site

City

Memphis

State/Province

Tennessee

ZIP/Postal Code

38119

Country

United States

Facility Name

GSK Investigational Site

City

Nashville

State/Province

Tennessee

ZIP/Postal Code

37203

Country

United States

Facility Name

GSK Investigational Site

City

Nashville

State/Province

Tennessee

ZIP/Postal Code

37212

Country

United States

Facility Name

GSK Investigational Site

City

Arlington

State/Province

Texas

ZIP/Postal Code

76014

Country

United States

Facility Name

GSK Investigational Site

City

Austin

State/Province

Texas

ZIP/Postal Code

78731

Country

United States

Facility Name

GSK Investigational Site

City

Bellaire

State/Province

Texas

ZIP/Postal Code

77401

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75216

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75231

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

ZIP/Postal Code

75234

Country

United States

Facility Name

GSK Investigational Site

City

Dallas

State/Province

Texas

Country

United States

Facility Name

GSK Investigational Site

City

El Paso

State/Province

Texas

ZIP/Postal Code

79925

Country

United States

Facility Name

GSK Investigational Site

City

Georgetown

State/Province

Texas

ZIP/Postal Code

78626

Country

United States

Facility Name

GSK Investigational Site

City

Houston

State/Province

Texas

ZIP/Postal Code

77070

Country

United States

Facility Name

GSK Investigational Site

City

Huntsville

State/Province

Texas

ZIP/Postal Code

77340

Country

United States

Facility Name

GSK Investigational Site

City

Kingwood

State/Province

Texas

ZIP/Postal Code

77339

Country

United States

Facility Name

GSK Investigational Site

City

Plano

State/Province

Texas

ZIP/Postal Code

75093

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78229

Country

United States

Facility Name

GSK Investigational Site

City

San Antonio

State/Province

Texas

ZIP/Postal Code

78258

Country

United States

Facility Name

GSK Investigational Site

City

Schertz

State/Province

Texas

ZIP/Postal Code

78154

Country

United States

Facility Name

GSK Investigational Site

City

Suite 101

State/Province

Texas

ZIP/Postal Code

76132

Country

United States

Facility Name

GSK Investigational Site

City

Tyler

State/Province

Texas

ZIP/Postal Code

75708

Country

United States

Facility Name

GSK Investigational Site

City

Layton

State/Province

Utah

ZIP/Postal Code

84401

Country

United States

Facility Name

GSK Investigational Site

City

Manassas

State/Province

Virginia

ZIP/Postal Code

20109

Country

United States

Facility Name

GSK Investigational Site

City

Federal Way

State/Province

Washington

ZIP/Postal Code

98003

Country

United States

Facility Name

GSK Investigational Site

City

Spokane

State/Province

Washington

ZIP/Postal Code

99208

Country

United States

Facility Name

GSK Investigational Site

City

Tacoma

State/Province

Washington

ZIP/Postal Code

98405

Country

United States

Facility Name

GSK Investigational Site

City

Wenatchee

State/Province

Washington

ZIP/Postal Code

98801

Country

United States

Facility Name

GSK Investigational Site

City

Madison

State/Province

Wisconsin

ZIP/Postal Code

53713

Country

United States

Facility Name

GSK Investigational Site

City

Adrogue

State/Province

Buenos Aires

ZIP/Postal Code

B1846DSK

Country

Argentina

Facility Name

GSK Investigational Site

City

Bahia Blanca

State/Province

Buenos Aires

ZIP/Postal Code

B8000FTD

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

State/Province

Buenos Aires

ZIP/Postal Code

1205

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

State/Province

Buenos Aires

ZIP/Postal Code

C1179AAB

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad autónoma de Buenos Aires

State/Province

Buenos Aires

ZIP/Postal Code

C141AH

Country

Argentina

Facility Name

GSK Investigational Site

City

Mar del Plata

State/Province

Buenos Aires

ZIP/Postal Code

B7600FZN

Country

Argentina

Facility Name

GSK Investigational Site

City

Mar del Plata

State/Province

Buenos Aires

Country

Argentina

Facility Name

GSK Investigational Site

City

Pergamino

State/Province

Buenos Aires

ZIP/Postal Code

B2700CPM

Country

Argentina

Facility Name

GSK Investigational Site

City

Córdoba

State/Province

Córdova

ZIP/Postal Code

5000

Country

Argentina

Facility Name

GSK Investigational Site

City

Godoy Cruz

State/Province

Mendoza

ZIP/Postal Code

M5501ARP

Country

Argentina

Facility Name

GSK Investigational Site

City

San Rafael

State/Province

Mendoza

ZIP/Postal Code

5600

Country

Argentina

Facility Name

GSK Investigational Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

2000

Country

Argentina

Facility Name

GSK Investigational Site

City

Rosario

State/Province

Santa Fe

ZIP/Postal Code

S2000C

Country

Argentina

Facility Name

GSK Investigational Site

City

Berazategui

ZIP/Postal Code

1886

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

1093

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

1407

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

C1061ABD

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

C1180A

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

ZIP/Postal Code

C1425AGC

Country

Argentina

Facility Name

GSK Investigational Site

City

Buenos Aires

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

ZIP/Postal Code

C1056ABJ

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

ZIP/Postal Code

C1406BOA

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autonoma de Buenos Aires

ZIP/Postal Code

C1428D

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autónoma de Buenos Aires

ZIP/Postal Code

C1128A

Country

Argentina

Facility Name

GSK Investigational Site

City

Ciudad Autónoma de Buenos Aires

ZIP/Postal Code

C1426A

Country

Argentina

Facility Name

GSK Investigational Site

City

Cordoba

ZIP/Postal Code

5016

Country

Argentina

Facility Name

GSK Investigational Site

City

La Plata

ZIP/Postal Code

B1902C

Country

Argentina

Facility Name

GSK Investigational Site

City

Mendoza

ZIP/Postal Code

5500

Country

Argentina

Facility Name

GSK Investigational Site

City

Mendoza

ZIP/Postal Code

M5500CCE

Country

Argentina

Facility Name

GSK Investigational Site

City

Mendoza

ZIP/Postal Code

M5500C

Country

Argentina

Facility Name

GSK Investigational Site

City

Santa Fe

ZIP/Postal Code

3000

Country

Argentina

Facility Name

GSK Investigational Site

City

Bonheiden

ZIP/Postal Code

2820

Country

Belgium

Facility Name

GSK Investigational Site

City

Brussels

ZIP/Postal Code

1090

Country

Belgium

Facility Name

GSK Investigational Site

City

Bruxelles

ZIP/Postal Code

1070

Country

Belgium

Facility Name

GSK Investigational Site

City

Edegem

ZIP/Postal Code

2650

Country

Belgium

Facility Name

GSK Investigational Site

City

Leuven

ZIP/Postal Code

3000

Country

Belgium

Facility Name

GSK Investigational Site

City

Liège

ZIP/Postal Code

4000

Country

Belgium

Facility Name

GSK Investigational Site

City

Roeselare

ZIP/Postal Code

8800

Country

Belgium

Facility Name

GSK Investigational Site

City

Byala

ZIP/Postal Code

7100

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Gabrovo

ZIP/Postal Code

5300

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Montana

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sevlievo

ZIP/Postal Code

5400

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sofia

ZIP/Postal Code

1202

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sofia

ZIP/Postal Code

1407

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Sofia

ZIP/Postal Code

1632

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Stara Zagora

ZIP/Postal Code

6000

Country

Bulgaria

Facility Name

GSK Investigational Site

City

Kelowna

State/Province

British Columbia

ZIP/Postal Code

V1Y 1V6

Country

Canada

Facility Name

GSK Investigational Site

City

Surrey

State/Province

British Columbia

ZIP/Postal Code

V3V 0C6

Country

Canada

Facility Name

GSK Investigational Site

City

Victoria

State/Province

British Columbia

ZIP/Postal Code

V8R 4R2

Country

Canada

Facility Name

GSK Investigational Site

City

Victoria

State/Province

British Columbia

ZIP/Postal Code

V8V 4A

Country

Canada

Facility Name

GSK Investigational Site

City

Winnipeg

State/Province

Manitoba

ZIP/Postal Code

Country

Canada

Facility Name

GSK Investigational Site

City

Moncton

State/Province

New Brunswick

ZIP/Postal Code

E1G 1A7

Country

Canada

Facility Name

GSK Investigational Site

City

St. John's

State/Province

Newfoundland and Labrador

ZIP/Postal Code

A1B 3V6

Country

Canada

Facility Name

GSK Investigational Site

City

Halifax

State/Province

Nova Scotia

ZIP/Postal Code

B3H 1V7

Country

Canada

Facility Name

GSK Investigational Site

City

Truro

State/Province

Nova Scotia

ZIP/Postal Code

B2N 1L2

Country

Canada

Facility Name

GSK Investigational Site

City

Brampton

State/Province

Ontario

ZIP/Postal Code

L6Z 4N5

Country

Canada

Facility Name

GSK Investigational Site

City

Burlington

State/Province

Ontario

ZIP/Postal Code

L7M 4Y

Country

Canada

Facility Name

GSK Investigational Site

City

Cambridge

State/Province

Ontario

ZIP/Postal Code

N1R 7R1

Country

Canada

Facility Name

GSK Investigational Site

City

Cornwall

State/Province

Ontario

ZIP/Postal Code

K6H4M4

Country

Canada

Facility Name

GSK Investigational Site

City

Corunna

State/Province

Ontario

ZIP/Postal Code

N0N 1G

Country

Canada

Facility Name

GSK Investigational Site

City

Hamilton

State/Province

Ontario

ZIP/Postal Code

L8L 2X2

Country

Canada

Facility Name

GSK Investigational Site

City

London

State/Province

Ontario

ZIP/Postal Code

N5W 6A

Country

Canada

Facility Name

GSK Investigational Site

City

London

State/Province

Ontario

ZIP/Postal Code

N6A 4V2

Country

Canada

Facility Name

GSK Investigational Site

City

Sarnia

State/Province

Ontario

ZIP/Postal Code

N7T 4X

Country

Canada

Facility Name

GSK Investigational Site

City

Smiths Falls

State/Province

Ontario

ZIP/Postal Code

K7A 4W8

Country

Canada

Facility Name

GSK Investigational Site

City

Sudbury

State/Province

Ontario

ZIP/Postal Code

P3A 5H

Country

Canada

Facility Name

GSK Investigational Site

City

Toronto

State/Province

Ontario

ZIP/Postal Code

M9V 4B

Country

Canada

Facility Name

GSK Investigational Site

City

Brossard

State/Province

Quebec

ZIP/Postal Code

J4Z 2K

Country

Canada

Facility Name

GSK Investigational Site

City

Chicoutimi

State/Province

Quebec

ZIP/Postal Code

G7H 7K9

Country

Canada

Facility Name

GSK Investigational Site

City

Greenfield Park

State/Province

Quebec

ZIP/Postal Code

J4V 2G

Country

Canada

Facility Name

GSK Investigational Site

City

Greenfield Park

State/Province

Quebec

ZIP/Postal Code

J4V 2H1

Country

Canada

Facility Name

GSK Investigational Site

City

Laval

State/Province

Quebec

ZIP/Postal Code

H7T 2P5

Country

Canada

Facility Name

GSK Investigational Site

City

Levis

State/Province

Quebec

ZIP/Postal Code

G6V 4Z5

Country

Canada

Facility Name

GSK Investigational Site

City

Montreal

State/Province

Quebec

ZIP/Postal Code

H4N 2W

Country

Canada

Facility Name

GSK Investigational Site

City

Sherbrooke

State/Province

Quebec

ZIP/Postal Code

J1J 2E3

Country

Canada

Facility Name

GSK Investigational Site

City

St-Charles-Borromée

State/Province

Quebec

ZIP/Postal Code

J6E 6J2

Country

Canada

Facility Name

GSK Investigational Site

City

St-Lambert

State/Province

Quebec

ZIP/Postal Code

J4P 2J

Country

Canada

Facility Name

GSK Investigational Site

City

Trois-Rivieres

State/Province

Quebec

ZIP/Postal Code

G8T 7A1

Country

Canada

Facility Name

GSK Investigational Site

City

Beroun

ZIP/Postal Code

266 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Krnov

ZIP/Postal Code

794 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Olomouc

ZIP/Postal Code

772 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Ostrava

ZIP/Postal Code

702 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 10

ZIP/Postal Code

100 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 1

ZIP/Postal Code

116 94

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 2

ZIP/Postal Code

128 08

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 4

ZIP/Postal Code

149 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Praha 5

ZIP/Postal Code

150 00

Country

Czechia

Facility Name

GSK Investigational Site

City

Pribram 1

ZIP/Postal Code

261 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Uherske Hradiste

ZIP/Postal Code

686 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Usti nad Labem

ZIP/Postal Code

401 13

Country

Czechia

Facility Name

GSK Investigational Site

City

Zlin

ZIP/Postal Code

760 01

Country

Czechia

Facility Name

GSK Investigational Site

City

Copenhagen

ZIP/Postal Code

2100

Country

Denmark

Facility Name

GSK Investigational Site

City

Esbjerg

ZIP/Postal Code

6700

Country

Denmark

Facility Name

GSK Investigational Site

City

Frederikssund

ZIP/Postal Code

DK-3600

Country

Denmark

Facility Name

GSK Investigational Site

City

Hellerup

ZIP/Postal Code

2900

Country

Denmark

Facility Name

GSK Investigational Site

City

Herlev

ZIP/Postal Code

DK-273

Country

Denmark

Facility Name

GSK Investigational Site

City

Holbæk

ZIP/Postal Code

DK-430

Country

Denmark

Facility Name

GSK Investigational Site

City

Hvidovre

ZIP/Postal Code

2650

Country

Denmark

Facility Name

GSK Investigational Site

City

København NV

ZIP/Postal Code

2400

Country

Denmark

Facility Name

GSK Investigational Site

City

København S

ZIP/Postal Code

DK-230

Country

Denmark

Facility Name

GSK Investigational Site

City

Roskilde

ZIP/Postal Code

DK-400

Country

Denmark

Facility Name

GSK Investigational Site

City

Amiens Cedex 1

ZIP/Postal Code

80054

Country

France

Facility Name

GSK Investigational Site

City

Broglie

ZIP/Postal Code

27270

Country

France

Facility Name

GSK Investigational Site

City

Corbeil-Essonnes

ZIP/Postal Code

91106

Country

France

Facility Name

GSK Investigational Site

City

La Rochelle Cedex 1

ZIP/Postal Code

17019

Country

France

Facility Name

GSK Investigational Site

City

Nantes cedex 2

ZIP/Postal Code

44277

Country

France

Facility Name

GSK Investigational Site

City

Narbonne

ZIP/Postal Code

11100

Country

France

Facility Name

GSK Investigational Site

City

Paris

ZIP/Postal Code

75010

Country

France

Facility Name

GSK Investigational Site

City

Pau Cedex

ZIP/Postal Code

64046

Country

France

Facility Name

GSK Investigational Site

City

Pierre-Bénite

ZIP/Postal Code

69310

Country

France

Facility Name

GSK Investigational Site

City

Strasbourg cedex

ZIP/Postal Code

67091

Country

France

Facility Name

GSK Investigational Site

City

Vandœuvre-lès-Nancy

ZIP/Postal Code

54511

Country

France

Facility Name

GSK Investigational Site

City

Deggingen

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

73326

Country

Germany

Facility Name

GSK Investigational Site

City

Freiburg

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

79106

Country

Germany

Facility Name

GSK Investigational Site

City

Gueglingen

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

74363

Country

Germany

Facility Name

GSK Investigational Site

City

Karlsruhe

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

76199

Country

Germany

Facility Name

GSK Investigational Site

City

Ludwigsburg

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

71640

Country

Germany

Facility Name

GSK Investigational Site

City

Stuttgart

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

70199

Country

Germany

Facility Name

GSK Investigational Site

City

Stuttgart

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

70378

Country

Germany

Facility Name

GSK Investigational Site

City

Villingen-Schwenningen

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

78048

Country

Germany

Facility Name

GSK Investigational Site

City

Wangen

State/Province

Baden-Wuerttemberg

ZIP/Postal Code

88239

Country

Germany

Facility Name

GSK Investigational Site

City

Aschaffenburg

State/Province

Bayern

ZIP/Postal Code

63739

Country

Germany

Facility Name

GSK Investigational Site

City

Dachau

State/Province

Bayern

ZIP/Postal Code

85221

Country

Germany

Facility Name

GSK Investigational Site

City

Haag

State/Province

Bayern

ZIP/Postal Code

83527

Country

Germany

Facility Name

GSK Investigational Site

City

Kuenzing

State/Province

Bayern

ZIP/Postal Code

94550

Country

Germany

Facility Name

GSK Investigational Site

City

Rednitzhembach

State/Province

Bayern

ZIP/Postal Code

91126

Country

Germany

Facility Name

GSK Investigational Site

City

Wallerfing

State/Province

Bayern

ZIP/Postal Code

94574

Country

Germany

Facility Name

GSK Investigational Site

City

Elsterwerda

State/Province

Brandenburg

ZIP/Postal Code

04910

Country

Germany

Facility Name

GSK Investigational Site

City

Falkensee

State/Province

Brandenburg

ZIP/Postal Code

14612

Country

Germany

Facility Name

GSK Investigational Site

City

Potsdam

State/Province

Brandenburg

ZIP/Postal Code

14469

Country

Germany

Facility Name

GSK Investigational Site

City

Floersheim

State/Province

Hessen

ZIP/Postal Code

65439

Country

Germany

Facility Name

GSK Investigational Site

City

Gelnhausen

State/Province

Hessen

ZIP/Postal Code

63571

Country

Germany

Facility Name

GSK Investigational Site

City

Hildesheim

State/Province

Niedersachsen

ZIP/Postal Code

31139

Country

Germany

Facility Name

GSK Investigational Site

City

Stuhr

State/Province

Niedersachsen

ZIP/Postal Code

28816

Country

Germany

Facility Name

GSK Investigational Site

City

Wardenburg

State/Province

Niedersachsen

ZIP/Postal Code

26203

Country

Germany

Facility Name

GSK Investigational Site

City

Bad Oeynhausen

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

32545

Country

Germany

Facility Name

GSK Investigational Site

City

Bochum

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

44791

Country

Germany

Facility Name

GSK Investigational Site

City

Bochum

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

44869

Country

Germany

Facility Name

GSK Investigational Site

City

Essen

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

45136

Country

Germany

Facility Name

GSK Investigational Site

City

Essen

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

45329

Country

Germany

Facility Name

GSK Investigational Site

City

Essen

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

45359

Country

Germany

Facility Name

GSK Investigational Site

City

Kleve

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

47533

Country

Germany

Facility Name

GSK Investigational Site

City

Koeln

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

51069

Country

Germany

Facility Name

GSK Investigational Site

City

Muenster

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

48145

Country

Germany

Facility Name

GSK Investigational Site

City

Witten

State/Province

Nordrhein-Westfalen

ZIP/Postal Code

58455

Country

Germany

Facility Name

GSK Investigational Site

City

Bad Kreuznach

State/Province

Rheinland-Pfalz

ZIP/Postal Code

55545

Country

Germany

Facility Name

GSK Investigational Site

City

Ludwigshafen am Rhein

State/Province

Rheinland-Pfalz

ZIP/Postal Code

67059

Country

Germany

Facility Name

GSK Investigational Site

City

Mainz

State/Province

Rheinland-Pfalz

ZIP/Postal Code

55116

Country

Germany

Facility Name

GSK Investigational Site

City

Sankt Ingbert

State/Province

Saarland

ZIP/Postal Code

66386

Country

Germany

Facility Name

GSK Investigational Site

City

Hohenmoelsen

State/Province

Sachsen-Anhalt

ZIP/Postal Code

06679

Country

Germany

Facility Name

GSK Investigational Site

City

Jerichow

State/Province

Sachsen-Anhalt

ZIP/Postal Code

39319

Country

Germany

Facility Name

GSK Investigational Site

City

Magdeburg

State/Province

Sachsen-Anhalt

ZIP/Postal Code

39112

Country

Germany

Facility Name

GSK Investigational Site

City

Chemnitz

State/Province

Sachsen

ZIP/Postal Code

09113

Country

Germany

Facility Name

GSK Investigational Site

City

Delitzsch

State/Province

Sachsen

ZIP/Postal Code

04509

Country

Germany

Facility Name

GSK Investigational Site

City

Dresden

State/Province

Sachsen

ZIP/Postal Code

01069

Country

Germany

Facility Name

GSK Investigational Site

City

Dresden

State/Province

Sachsen

ZIP/Postal Code

01219

Country

Germany

Facility Name

GSK Investigational Site

City

Dresden

State/Province

Sachsen

ZIP/Postal Code

01279

Country

Germany

Facility Name

GSK Investigational Site

City

Dresden

State/Province

Sachsen

ZIP/Postal Code

01307

Country

Germany

Facility Name

GSK Investigational Site

City

Leipzg

State/Province

Sachsen

ZIP/Postal Code

04109

Country

Germany

Facility Name

GSK Investigational Site

City

Leipzig

State/Province

Sachsen

ZIP/Postal Code

04109

Country

Germany

Facility Name

GSK Investigational Site

City

Leipzig

State/Province

Sachsen

ZIP/Postal Code

04249

Country

Germany

Facility Name

GSK Investigational Site

City

Oschatz

State/Province

Sachsen

ZIP/Postal Code

04758

Country

Germany

Facility Name

GSK Investigational Site

City

Pirna

State/Province

Sachsen

ZIP/Postal Code

01796

Country

Germany

Facility Name

GSK Investigational Site

City

Riesa

State/Province

Sachsen

ZIP/Postal Code

01587

Country

Germany

Facility Name

GSK Investigational Site

City

Schkeuditz

State/Province

Sachsen

ZIP/Postal Code

04435

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

10117

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

10409

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

10789

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

12157

Country

Germany

Facility Name

GSK Investigational Site

City

Berlin

ZIP/Postal Code

13405

Country

Germany

Facility Name

GSK Investigational Site

City

Dortmund

ZIP/Postal Code

44137

Country

Germany

Facility Name

GSK Investigational Site

City

Hamburg

ZIP/Postal Code

20099

Country

Germany

Facility Name

GSK Investigational Site

City

Hamburg

ZIP/Postal Code

21073

Country

Germany

Facility Name

GSK Investigational Site

City

Hamburg

ZIP/Postal Code

22041

Country

Germany

Facility Name

GSK Investigational Site

City

Mannheim

ZIP/Postal Code

68163

Country

Germany

Facility Name

GSK Investigational Site

City

Muenchen

ZIP/Postal Code

80809

Country

Germany

Facility Name

GSK Investigational Site

City

Alexandroupolis

ZIP/Postal Code

68 100

Country

Greece

Facility Name

GSK Investigational Site

City

Athens,

ZIP/Postal Code

11 527

Country

Greece

Facility Name

GSK Investigational Site

City

Athens

ZIP/Postal Code

11521

Country

Greece

Facility Name

GSK Investigational Site

City

Athens

ZIP/Postal Code

11528

Country

Greece

Facility Name

GSK Investigational Site

City

Haidari, Athens

ZIP/Postal Code

12462

Country

Greece

Facility Name

GSK Investigational Site

City

Heraklion, Crete

ZIP/Postal Code

71409

Country

Greece

Facility Name

GSK Investigational Site

City

Ioannina

ZIP/Postal Code

45500

Country

Greece

Facility Name

GSK Investigational Site

City

Lamia

ZIP/Postal Code

35100

Country

Greece

Facility Name

GSK Investigational Site

City

Nikaia Piraeus

ZIP/Postal Code

184 54

Country

Greece

Facility Name

GSK Investigational Site

City

Pireas

ZIP/Postal Code

18536

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

546 36

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

546 42

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

54642

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

564 29

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

570 01

Country

Greece

Facility Name

GSK Investigational Site

City

Thessaloniki

ZIP/Postal Code

570 10

Country

Greece

Facility Name

GSK Investigational Site

City

Hong Kong

Country

Hong Kong

Facility Name

GSK Investigational Site

City

Shatin

Country

Hong Kong

Facility Name

GSK Investigational Site

City

Baja

ZIP/Postal Code

6500

Country

Hungary

Facility Name

GSK Investigational Site

City

Budapest

ZIP/Postal Code

1036

Country

Hungary

Facility Name

GSK Investigational Site

City

Budapest

ZIP/Postal Code

1135

Country

Hungary

Facility Name

GSK Investigational Site

City

Debrecen

ZIP/Postal Code

4026

Country

Hungary

Facility Name

GSK Investigational Site

City

Debrecen

ZIP/Postal Code

4031

Country

Hungary

Facility Name

GSK Investigational Site

City

Eger

ZIP/Postal Code

3300

Country

Hungary

Facility Name

GSK Investigational Site

City

Gödöllő

ZIP/Postal Code

2100

Country

Hungary

Facility Name

GSK Investigational Site

City

Hatvan

ZIP/Postal Code

3000

Country

Hungary

Facility Name

GSK Investigational Site

City

Komarom

ZIP/Postal Code

2900

Country

Hungary

Facility Name

GSK Investigational Site

City

Miskolc

ZIP/Postal Code

3529

Country

Hungary

Facility Name

GSK Investigational Site

City

Sátoraljaújhely

ZIP/Postal Code

3980

Country

Hungary

Facility Name

GSK Investigational Site

City

Chieti

State/Province

Abruzzo

ZIP/Postal Code

66100

Country

Italy

Facility Name

GSK Investigational Site

City

Catanzaro

State/Province

Calabria

ZIP/Postal Code

88100

Country

Italy

Facility Name

GSK Investigational Site

City

Napoli

State/Province

Campania

ZIP/Postal Code

80131

Country

Italy

Facility Name

GSK Investigational Site

City

Napoli

State/Province

Campania

ZIP/Postal Code

80138

Country

Italy

Facility Name

GSK Investigational Site

City

Bologna

State/Province

Emilia-Romagna

ZIP/Postal Code

40138

Country

Italy

Facility Name

GSK Investigational Site

City

Parma

State/Province

Emilia-Romagna

ZIP/Postal Code

43100

Country

Italy

Facility Name

GSK Investigational Site

City

Ravenna

State/Province

Emilia-Romagna

ZIP/Postal Code

48121

Country

Italy

Facility Name

GSK Investigational Site

City

Roma

State/Province

Lazio

ZIP/Postal Code

00133

Country

Italy

Facility Name

GSK Investigational Site

City

Roma

State/Province

Lazio

ZIP/Postal Code

00168

Country

Italy

Facility Name

GSK Investigational Site

City

Roma

State/Province

Lazio

ZIP/Postal Code

00186

Country

Italy

Facility Name

GSK Investigational Site

City

Arenzano (GE)

State/Province

Liguria

ZIP/Postal Code

16011

Country

Italy

Facility Name

GSK Investigational Site

City

Bergamo

State/Province

Lombardia

ZIP/Postal Code

24127

Country

Italy

Facility Name

GSK Investigational Site

City

Milano

State/Province

Lombardia

ZIP/Postal Code

20122

Country

Italy

Facility Name

GSK Investigational Site

City

Milano

State/Province

Lombardia

ZIP/Postal Code

20132

Country

Italy

Facility Name

GSK Investigational Site

City

Milano

State/Province

Lombardia

ZIP/Postal Code

20142

Country

Italy

Facility Name

GSK Investigational Site

City

Vigevano (PV)

State/Province

Lombardia

ZIP/Postal Code

27029

Country

Italy

Facility Name

GSK Investigational Site

City

Ancona

State/Province

Marche

ZIP/Postal Code

60131

Country

Italy

Facility Name

GSK Investigational Site

City

Ascoli Piceno

State/Province

Marche

ZIP/Postal Code

63100

Country

Italy

Facility Name

GSK Investigational Site

City

Bari

State/Province

Puglia

ZIP/Postal Code

70124

Country

Italy

Facility Name

GSK Investigational Site

City

San Giovanni Rotondo (FG)

State/Province

Puglia

ZIP/Postal Code

71013

Country

Italy

Facility Name

GSK Investigational Site

City

Olbia (OT)

State/Province

Sardegna

ZIP/Postal Code

07026

Country

Italy

Facility Name

GSK Investigational Site

City

Siena

State/Province

Toscana

ZIP/Postal Code

53100

Country

Italy

Facility Name

GSK Investigational Site

City

S.Andrea Delle Fratte - S. Sisto (PG)

State/Province

Umbria

ZIP/Postal Code

06132

Country

Italy

Facility Name

GSK Investigational Site

City

Padova

State/Province

Veneto

ZIP/Postal Code

35128

Country

Italy

Facility Name

GSK Investigational Site

City

Daegu

ZIP/Postal Code

42415

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Daegu

ZIP/Postal Code

700-71

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Gyeonggi-do

ZIP/Postal Code

463-70

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Gyeonggido

ZIP/Postal Code

420-717

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Kangwondo

ZIP/Postal Code

220-701

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Pusan

ZIP/Postal Code

602-73

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

110-744

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

120-752

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

134-72

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

135-71

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

135-72

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

137-70

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

150-95

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

152-703

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Seoul

ZIP/Postal Code

411-70

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Suwon, Kyonggi-do

ZIP/Postal Code

443-72

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Suwon

ZIP/Postal Code

442-723

Country

Korea, Republic of

Facility Name

GSK Investigational Site

City

Aguascalientes, Ags

State/Province

Aguascalientes

ZIP/Postal Code

20127

Country

Mexico

Facility Name

GSK Investigational Site

City

Guadalajara

State/Province

Jalisco

ZIP/Postal Code

44150

Country

Mexico

Facility Name

GSK Investigational Site

City

Guadalajara

State/Province

Jalisco

ZIP/Postal Code

44600

Country

Mexico

Facility Name

GSK Investigational Site

City

Guadalajara

State/Province

Jalisco

ZIP/Postal Code

45116

Country

Mexico

Facility Name

GSK Investigational Site

City

Tlaquepaque

State/Province

Jalisco

ZIP/Postal Code

45510

Country

Mexico

Facility Name

GSK Investigational Site

City

Monterrey NL

State/Province

Nuevo León

ZIP/Postal Code

64718

Country

Mexico

Facility Name

GSK Investigational Site

City

Monterrey

State/Province

Nuevo León

ZIP/Postal Code

64460

Country

Mexico

Facility Name

GSK Investigational Site

City

Queretaro

State/Province

Querétaro

ZIP/Postal Code

76000

Country

Mexico

Facility Name

GSK Investigational Site

City

Mazatlán

State/Province

Sinaloa

ZIP/Postal Code

82126

Country

Mexico

Facility Name

GSK Investigational Site

City

Mazatlán

State/Province

Sinaloa

Country

Mexico

Facility Name

GSK Investigational Site

City

Mérida

State/Province

Yucatán

ZIP/Postal Code

97129

Country

Mexico

Facility Name

GSK Investigational Site

City

Aguascalientes

ZIP/Postal Code

20230

Country

Mexico

Facility Name

GSK Investigational Site

City

Mexico, D.F.

ZIP/Postal Code

11650

Country

Mexico

Facility Name

GSK Investigational Site

City

Alkmaar

ZIP/Postal Code

1815 JD

Country

Netherlands

Facility Name

GSK Investigational Site

City

Amsterdam

ZIP/Postal Code

1061 A

Country

Netherlands

Facility Name

GSK Investigational Site

City

Eindhoven

ZIP/Postal Code

5631 BM

Country

Netherlands

Facility Name

GSK Investigational Site

City

Gouda

ZIP/Postal Code

2803 H

Country

Netherlands

Facility Name

GSK Investigational Site

City

Hardenberg

ZIP/Postal Code

7772 SE

Country

Netherlands

Facility Name

GSK Investigational Site

City

Heerlen

ZIP/Postal Code

6419 PC

Country

Netherlands

Facility Name

GSK Investigational Site

City

Hoogeveen

ZIP/Postal Code

7909 A

Country

Netherlands

Facility Name

GSK Investigational Site

City

Meppel

ZIP/Postal Code

7943 K

Country

Netherlands

Facility Name

GSK Investigational Site

City

Rotterdam

ZIP/Postal Code

3051 G

Country

Netherlands

Facility Name

GSK Investigational Site

City

Sneek

ZIP/Postal Code

8601 Z

Country

Netherlands

Facility Name

GSK Investigational Site

City

Hoenefoss

ZIP/Postal Code

3513

Country

Norway

Facility Name

GSK Investigational Site

City

Kolbjørnsvik

ZIP/Postal Code

4816

Country

Norway

Facility Name

GSK Investigational Site

City

Oslo

ZIP/Postal Code

0319

Country

Norway

Facility Name

GSK Investigational Site

City

Oslo

ZIP/Postal Code

0586

Country

Norway

Facility Name

GSK Investigational Site

City

Stavanger

ZIP/Postal Code

4011

Country

Norway

Facility Name

GSK Investigational Site

City

Trujillo

State/Province

La Libertad

ZIP/Postal Code

13001

Country

Peru

Facility Name

GSK Investigational Site

City

Callao

State/Province

Lima

ZIP/Postal Code

Callao 2

Country

Peru

Facility Name

GSK Investigational Site

City

San Martin de Porres

State/Province

Lima

ZIP/Postal Code

Lima 33

Country

Peru

Facility Name

GSK Investigational Site

City

Arequipa

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 14

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 29

Country

Peru

Facility Name

GSK Investigational Site

City

Lima

ZIP/Postal Code

Lima 32

Country

Peru

Facility Name

GSK Investigational Site

City

Piura

ZIP/Postal Code

20001

Country

Peru

Facility Name

GSK Investigational Site

City

Cebu City

ZIP/Postal Code

6000

Country

Philippines

Facility Name

GSK Investigational Site

City

Iloilo City

ZIP/Postal Code

5000

Country

Philippines

Facility Name

GSK Investigational Site

City

Laoag City

ZIP/Postal Code

2900

Country

Philippines

Facility Name

GSK Investigational Site

City

Bialystok

ZIP/Postal Code

15-435

Country

Poland

Facility Name

GSK Investigational Site

City

Bydgoszcz

ZIP/Postal Code

85-231

Country

Poland

Facility Name

GSK Investigational Site

City

Bydgoszcz

ZIP/Postal Code

85-863

Country

Poland

Facility Name

GSK Investigational Site

City

Gdansk

ZIP/Postal Code

80-858

Country

Poland

Facility Name

GSK Investigational Site

City

Gniewkowo

ZIP/Postal Code

88-140

Country

Poland

Facility Name

GSK Investigational Site

City

Katowice

ZIP/Postal Code

40-081

Country

Poland

Facility Name

GSK Investigational Site

City

Katowice

ZIP/Postal Code

40-772

Country

Poland

Facility Name

GSK Investigational Site

City

Krakow

ZIP/Postal Code

30-539

Country

Poland

Facility Name

GSK Investigational Site

City

Krakow

ZIP/Postal Code

31-261

Country

Poland

Facility Name

GSK Investigational Site

City

Krakow

ZIP/Postal Code

31-530

Country

Poland

Facility Name

GSK Investigational Site

City

Lublin

ZIP/Postal Code

20-538

Country

Poland

Facility Name

GSK Investigational Site

City

Poznan

ZIP/Postal Code

60-111

Country

Poland

Facility Name

GSK Investigational Site

City

Poznan

ZIP/Postal Code

61-655

Country

Poland

Facility Name

GSK Investigational Site

City

Sopot

ZIP/Postal Code

81- 71

Country

Poland

Facility Name

GSK Investigational Site

City

Warszawa

ZIP/Postal Code

00-465

Country

Poland

Facility Name

GSK Investigational Site

City

Wierzchoslawice

ZIP/Postal Code

33-122

Country

Poland

Facility Name

GSK Investigational Site

City

Wroclaw

ZIP/Postal Code

50-127

Country

Poland

Facility Name

GSK Investigational Site

City

Wroclaw

ZIP/Postal Code

50-981

Country

Poland

Facility Name

GSK Investigational Site

City

Wroclaw

ZIP/Postal Code

54-239

Country

Poland

Facility Name

GSK Investigational Site

City

Arkhangelsk

ZIP/Postal Code

163045

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Barnaul

ZIP/Postal Code

656 045

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Chelyabinsk

ZIP/Postal Code

454021

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Chelyabinsk

ZIP/Postal Code

454047

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Ekaterinburg

ZIP/Postal Code

620039

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Ekaterinburg

ZIP/Postal Code

620149

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Ivanovo

ZIP/Postal Code

153005

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Kemerovo

ZIP/Postal Code

650000

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Kemerovo

ZIP/Postal Code

650002

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Krasnodar

ZIP/Postal Code

350086

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

117 036

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

117 03

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

117292

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

119435

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

119992

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

127411

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Moscow

ZIP/Postal Code

129110

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Nizhniy Novgorod

ZIP/Postal Code

603126

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Nizhny Novgorod

ZIP/Postal Code

603003

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Novosibirsk

ZIP/Postal Code

630047

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Novosibirsk

ZIP/Postal Code

630091

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Perm

ZIP/Postal Code

614097

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Rostov-on-Don

ZIP/Postal Code

344022

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Ryazan

ZIP/Postal Code

390039

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saint Petersburg

ZIP/Postal Code

195257

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Samara

ZIP/Postal Code

443067

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Saratov

ZIP/Postal Code

410053

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Tomsk

ZIP/Postal Code

634012

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Tomsk

ZIP/Postal Code

634041

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Tomsk

ZIP/Postal Code

634050

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Voronezh

ZIP/Postal Code

394018

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Yaroslavl

ZIP/Postal Code

150000

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Yaroslavl

ZIP/Postal Code

150003

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Yaroslavl

ZIP/Postal Code

150010

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Yaroslavl

ZIP/Postal Code

150030

Country

Russian Federation

Facility Name

GSK Investigational Site

City

Bloemfontein

State/Province

Free State

ZIP/Postal Code

9301

Country

South Africa

Facility Name

GSK Investigational Site

City

Tongaat

State/Province

KwaZulu- Natal

ZIP/Postal Code

4400

Country

South Africa

Facility Name

GSK Investigational Site

City

Bloemfontein

ZIP/Postal Code

9301

Country

South Africa

Facility Name

GSK Investigational Site

City

Cape Town

ZIP/Postal Code

7500

Country

South Africa

Facility Name

GSK Investigational Site

City

Houghton

ZIP/Postal Code

2198

Country

South Africa

Facility Name

GSK Investigational Site

City

Kuilsrivier

ZIP/Postal Code

7580

Country

South Africa

Facility Name

GSK Investigational Site

City

Paarl

ZIP/Postal Code

7646

Country

South Africa

Facility Name

GSK Investigational Site

City

Pinelands

ZIP/Postal Code

7405

Country

South Africa

Facility Name

GSK Investigational Site

City

Umhlanga

ZIP/Postal Code

4319

Country

South Africa

Facility Name

GSK Investigational Site

City

Alicante

ZIP/Postal Code

03004

Country

Spain

Facility Name

GSK Investigational Site

City

Almeria

ZIP/Postal Code

4001

Country

Spain

Facility Name

GSK Investigational Site

City

Alzira/Valencia

ZIP/Postal Code

46600

Country

Spain

Facility Name

GSK Investigational Site

City

Badalona / Barcelona

ZIP/Postal Code

08917

Country

Spain

Facility Name

GSK Investigational Site

City

Badalona

ZIP/Postal Code

08916

Country

Spain

Facility Name

GSK Investigational Site

City

Barcelona

ZIP/Postal Code

08003

Country

Spain

Facility Name

GSK Investigational Site

City

Barcelona

ZIP/Postal Code

08006

Country

Spain

Facility Name

GSK Investigational Site

City

Barcelona

ZIP/Postal Code

08026

Country

Spain

Facility Name

GSK Investigational Site

City

Barcelona

ZIP/Postal Code

08907

Country

Spain

Facility Name

GSK Investigational Site

City

Boadilla Del Monte (Madrid)

ZIP/Postal Code

28660

Country

Spain

Facility Name

GSK Investigational Site

City

Canet De Mar - Barcelona

ZIP/Postal Code

08360

Country

Spain

Facility Name

GSK Investigational Site

City

Cangas Del Narcea/Asturias

ZIP/Postal Code

33800

Country

Spain

Facility Name

GSK Investigational Site

City

Centelles (Barcelona)

ZIP/Postal Code

08540

Country

Spain

Facility Name

GSK Investigational Site

City

Córdoba

ZIP/Postal Code

14004

Country

Spain

Facility Name

GSK Investigational Site

City

Elche

ZIP/Postal Code

03293

Country

Spain

Facility Name

GSK Investigational Site

City

Granada

ZIP/Postal Code

18012

Country

Spain

Facility Name

GSK Investigational Site

City

La Coruña

ZIP/Postal Code

15006

Country

Spain

Facility Name

GSK Investigational Site

City

León

ZIP/Postal Code

24071

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28006

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28034

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28040

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28046

Country

Spain

Facility Name

GSK Investigational Site

City

Madrid

ZIP/Postal Code

28050

Country

Spain

Facility Name

GSK Investigational Site

City

Malaga

ZIP/Postal Code

29010

Country

Spain

Facility Name

GSK Investigational Site

City

Málaga

ZIP/Postal Code

29010

Country

Spain

Facility Name

GSK Investigational Site

City

Palma de Mallorca

ZIP/Postal Code

07010

Country

Spain

Facility Name

GSK Investigational Site

City

Palma de Mallorca

ZIP/Postal Code

07198

Country

Spain

Facility Name

GSK Investigational Site

City

Pontevedra

ZIP/Postal Code

36071

Country

Spain

Facility Name

GSK Investigational Site

City

Pozuelo De Alarcón/Madrid

ZIP/Postal Code

28223

Country

Spain

Facility Name

GSK Investigational Site

City

Sagunto/Valencia

ZIP/Postal Code

46520

Country

Spain

Facility Name

GSK Investigational Site

City

San Juan (Alicante)

ZIP/Postal Code

03550

Country

Spain

Facility Name

GSK Investigational Site

City

Sanlucar De Barrameda - Cádiz

ZIP/Postal Code

11540

Country

Spain

Facility Name

GSK Investigational Site

City

Santa Coloma De Gramanet (Barcelona)

ZIP/Postal Code

08923

Country

Spain

Facility Name

GSK Investigational Site

City

Santiago De Compostela

ZIP/Postal Code

15706

Country

Spain

Facility Name

GSK Investigational Site

City

Sevilla

ZIP/Postal Code

41014

Country

Spain

Facility Name

GSK Investigational Site

City

Tarrasa, Barcelona

ZIP/Postal Code

08221

Country

Spain

Facility Name

GSK Investigational Site

City

Valencia

ZIP/Postal Code

46010

Country

Spain

Facility Name

GSK Investigational Site

City

Valencia

ZIP/Postal Code

46017

Country

Spain

Facility Name

GSK Investigational Site

City

Valencia

ZIP/Postal Code

46026

Country

Spain

Facility Name

GSK Investigational Site

City

Vigo-Pontevedra

ZIP/Postal Code

36312

Country

Spain

Facility Name

GSK Investigational Site

City

Borås

ZIP/Postal Code

SE-506

Country

Sweden

Facility Name

GSK Investigational Site

City

Eksjö

ZIP/Postal Code

SE-575 35

Country

Sweden

Facility Name

GSK Investigational Site

City

Göteborg

ZIP/Postal Code

SE-413 45

Country

Sweden

Facility Name

GSK Investigational Site

City

Helsingborg

ZIP/Postal Code

SE-252

Country

Sweden

Facility Name

GSK Investigational Site

City

Härnösand

ZIP/Postal Code

SE-871

Country

Sweden

Facility Name

GSK Investigational Site

City

Karlskrona

ZIP/Postal Code

SE-371 41

Country

Sweden

Facility Name

GSK Investigational Site

City

Kristianstad

ZIP/Postal Code

SE-291 85

Country

Sweden

Facility Name

GSK Investigational Site

City

Linköping

ZIP/Postal Code

SE-587 58

Country

Sweden

Facility Name

GSK Investigational Site

City

Ljungby

ZIP/Postal Code

SE-341

Country

Sweden

Facility Name

GSK Investigational Site

City

Malmö

ZIP/Postal Code

SE-205 02

Country

Sweden

Facility Name

GSK Investigational Site

City

Rättvik

ZIP/Postal Code

SE-795 30

Country

Sweden

Facility Name

GSK Investigational Site

City

Stockholm

ZIP/Postal Code

SE-111

Country

Sweden

Facility Name

GSK Investigational Site

City

Stockholm

ZIP/Postal Code

SE-113 61

Country

Sweden

Facility Name

GSK Investigational Site

City

Stockholm

ZIP/Postal Code

SE-182 88

Country

Sweden

Facility Name

GSK Investigational Site

City

Umeå

ZIP/Postal Code

SE-901 85

Country

Sweden

Facility Name

GSK Investigational Site

City

Uppsala

ZIP/Postal Code

SE-752

Country

Sweden

Facility Name

GSK Investigational Site

City

Örebro

ZIP/Postal Code

SE-703 62

Country

Sweden

Facility Name

GSK Investigational Site

City

Changhua

ZIP/Postal Code

500

Country

Taiwan

Facility Name

GSK Investigational Site

City

Hualien

ZIP/Postal Code

970

Country

Taiwan

Facility Name

GSK Investigational Site

City

Kaohsiung

ZIP/Postal Code

833

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taichung

ZIP/Postal Code

433

Country

Taiwan

Facility Name

GSK Investigational Site

City

Tainan

ZIP/Postal Code

71004

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taipei

ZIP/Postal Code

10002

Country

Taiwan

Facility Name

GSK Investigational Site

City

Taipei

ZIP/Postal Code

112

Country

Taiwan

Facility Name

GSK Investigational Site

City

Bangkok

ZIP/Postal Code

10330

Country

Thailand

Facility Name

GSK Investigational Site

City

Bangkok

ZIP/Postal Code

10400

Country

Thailand

Facility Name

GSK Investigational Site

City

Chiangmai

ZIP/Postal Code

50200

Country

Thailand

Facility Name

GSK Investigational Site

City

Pathumthani

ZIP/Postal Code

12120

Country

Thailand

Facility Name

GSK Investigational Site

City

Songkla

ZIP/Postal Code

90110

Country

Thailand

Facility Name

GSK Investigational Site

City

Chernivtsi

ZIP/Postal Code

58022

Country

Ukraine

Facility Name

GSK Investigational Site

City

Dnipropetrovsk

ZIP/Postal Code

49038

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kharkiv

ZIP/Postal Code

61058

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kharkiv

ZIP/Postal Code

61070

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kherson

ZIP/Postal Code

73000

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

01004

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

01021

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

02091

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

03049

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

04050

Country

Ukraine

Facility Name

GSK Investigational Site

City

Kyiv

ZIP/Postal Code

04114

Country

Ukraine

Facility Name

GSK Investigational Site

City

Mykolaiv

ZIP/Postal Code

54003

Country

Ukraine

Facility Name

GSK Investigational Site

City

Odesa

ZIP/Postal Code

65025

Country

Ukraine

Facility Name

GSK Investigational Site

City

Poltava

ZIP/Postal Code

36011

Country

Ukraine

Facility Name

GSK Investigational Site

City

Uzhgorod

ZIP/Postal Code

88000

Country

Ukraine

Facility Name

GSK Investigational Site

City

Vinnytsia

ZIP/Postal Code

21010

Country

Ukraine

Facility Name

GSK Investigational Site

City

Zaporizhzhya

ZIP/Postal Code

69001

Country

Ukraine

Facility Name

GSK Investigational Site

City

Soham

State/Province

Cambridgeshire

ZIP/Postal Code

CB7 5J

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Chesterfield

State/Province

Derbyshire

ZIP/Postal Code

S40 4AAA

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Romford

State/Province

Essex

ZIP/Postal Code

RM1 3P

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Northwood

State/Province

Middlesex

ZIP/Postal Code

HA6 2R

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Edinburgh

State/Province

Midlothian

ZIP/Postal Code

EH4 2XU

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Trowbridge

State/Province

Wiltshire

ZIP/Postal Code

BA14 8

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Aberdeen

ZIP/Postal Code

AB25 2

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Axbridge, Somerset

ZIP/Postal Code

BS26 2

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Ayr

ZIP/Postal Code

KA6 6D

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Blackpool

ZIP/Postal Code

FY3 8NR

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Bristol

ZIP/Postal Code

BS10 5

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Dumfries

ZIP/Postal Code

DG1 4AP

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Dundee

ZIP/Postal Code

DD1 9S

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Dundee

ZIP/Postal Code

DD4 6Q

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Dundee

ZIP/Postal Code

DD5 4LX

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Fife

ZIP/Postal Code

KY14 7AW

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Fife

ZIP/Postal Code

KY2 5A

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Gloucester

ZIP/Postal Code

GL1 3N

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Lancaster

ZIP/Postal Code

LA1 4R

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Manchester

ZIP/Postal Code

M23 9LT

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Newport

ZIP/Postal Code

PO30 5

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Oxford

ZIP/Postal Code

OX3 7L

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Rotherham

ZIP/Postal Code

S60 2UD

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Sidcup, Kent

ZIP/Postal Code

DA14 6

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Trowbridge

ZIP/Postal Code

BA14 9

Country

United Kingdom

Facility Name

GSK Investigational Site

City

Wigan

ZIP/Postal Code

WN1 2NN

Country

United Kingdom

12. IPD Sharing Statement

Citations:

PubMed Identifier

30015066

Citation

Green JB, Hernandez AF, D'Agostino RB, Granger CB, Janmohamed S, Jones NP, Leiter LA, Noronha D, Russell R, Sigmon K, Del Prato S, McMurray JJV. Harmony Outcomes: A randomized, double-blind, placebo-controlled trial of the effect of albiglutide on major cardiovascular events in patients with type 2 diabetes mellitus-Rationale, design, and baseline characteristics. Am Heart J. 2018 Sep;203:30-38. doi: 10.1016/j.ahj.2018.03.030. Epub 2018 Jun 12.

Results Reference

background

PubMed Identifier

34281607

Citation

O'Brien EC, Raman SR, Ellis A, Hammill BG, Berdan LG, Rorick T, Janmohamed S, Lampron Z, Hernandez AF, Curtis LH. The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study. Trials. 2021 Jul 19;22(1):465. doi: 10.1186/s13063-021-05397-0.

Results Reference

derived

PubMed Identifier

30291013

Citation

Hernandez AF, Green JB, Janmohamed S, D'Agostino RB Sr, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC, Thorpe KM, McMurray JJV, Del Prato S; Harmony Outcomes committees and investigators. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 2018 Oct 27;392(10157):1519-1529. doi: 10.1016/S0140-6736(18)32261-X. Epub 2018 Oct 2.

Results Reference

derived

PubMed Identifier

29693361

Citation

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, Latham K, Green JB. Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population. Am J Manag Care. 2018 Apr;24(8 Suppl):S146-S155.

Results Reference

derived

Learn more about this trial

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

We'll reach out to this number within 24 hrs

Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus

About this trial

Eligibility Criteria

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

1. Study Identification

2. Study Status

3. Sponsor/Collaborators

4. Oversight

5. Study Description

6. Conditions and Keywords

7. Study Design

8. Arms, Groups, and Interventions

10. Eligibility

12. IPD Sharing Statement

Learn more about this trial